In the last trading session, 5.31 million Telomir Pharmaceuticals Inc (NASDAQ:TELO) shares changed hands as the company’s beta touched -0.83. With the company’s per share price at $2.21 changed hands at -$0.07 or -3.07% during last session, the market valuation stood at $65.78M. TELO’s last price was a discount, traded about -280.09% off its 52-week high of $8.40. The share price had its 52-week low at $1.12, which suggests the last value was 49.32% up since then. When we look at Telomir Pharmaceuticals Inc’s average trading volume, we note the 10-day average is 16.82 million shares, with the 3-month average coming to 2.95 million.

Telomir Pharmaceuticals Inc (NASDAQ:TELO) trade information

Instantly TELO was in red as seen at the end of in last trading. With action 88.89%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -44.19%, with the 5-day performance at 88.89% in the green. However, in the 30-day time frame, Telomir Pharmaceuticals Inc (NASDAQ:TELO) is 25.57% up. Looking at the short shares, we see there were 2.09 million shares sold at short interest cover period of 8.69 days.

Telomir Pharmaceuticals Inc (NASDAQ:TELO)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 34.17% of Telomir Pharmaceuticals Inc shares while 12.53% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 19.03%. There are 12.53% institutions holding the Telomir Pharmaceuticals Inc stock share, with BLACKROCK INC. the top institutional holder. As of 2024-06-30, the company held 0.2969% of the shares, roughly 87899.0 TELO shares worth $0.42 million.

GEODE CAPITAL MANAGEMENT, LLC holds the second largest percentage of outstanding shares, with 0.2241% or 66355.0 shares worth $0.32 million as of 2024-06-30.